Overexpression and enhanced activation of c-MYC (referred to as MYC) have been identified as one of the major key drivers of MM and are associated with an aggressive phenotype of the disease [4], resulting in enhanced cell growth, proliferation, energy production, and anabolic metabolism [5,6]. Here, MYC is linked to Miyoshi myopathy.